Mirae Asset Global ETFs Holdings
NAUT icon

Mirae Asset Global ETFs Holdings’s Nautilus Biotechnolgy NAUT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,126
Closed -$25.1K – 3159
2025
Q1 		$25.1K Buy
29,126
+1,248
+4% +$1.85K ﹤0.01% 2959
2024
Q4 		$46.8K Buy
27,878
+1,216
+5% +$2.91K ﹤0.01% 2916
2024
Q3 		$76K Buy
26,662
+630
+2% +$1.63K ﹤0.01% 2811
2024
Q2 		$60.9K Buy
+26,032
New +$68K ﹤0.01% 2738

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NAUT Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 29,126 shares — an estimated $25.1K sold.

Mirae Asset Global ETFs Holdings first reported a position in NAUT in Q2 2024 and held it in 4 quarters. The position peaked at $76K in Q3 2024. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 29,126 Nautilus Biotechnolgy shares in Q2 2025, an estimated $25.1K.
  • Mirae Asset Global ETFs Holdings first reported a position in Nautilus Biotechnolgy in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Nautilus Biotechnolgy position peaked at $76K in Q3 2024.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.